Stand aside — setup invalidated
Setup score 89, but price closes below stop $423.87 — stand aside until the condition resets.
Simple research view
AMGN · Amgen Inc.
$382.47 -2.25% Sep 10 close
1 independent risk warning also present. Review before relying on the bullish setup.
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$AMGN
Amgen Inc.Amgen Inc. is a mega-cap Biotechnology company in the Health Technology sector with a market cap of $207B.
⚠ Risk Signals
Rising Wedge
prior_advance=39.3%, converging=yes, narrowing=14%, touches=upper:2/lower:3, trigger=broke
Bearish structure on the daily chart — a heads-up for anyone holding, not a short signal. Does not affect the bullish setup score.
Historical verdict · setup score 89/100 · data Sep 10 close · 1 session old
Stand aside — setup invalidated
Setup score 89, but price closes below stop $423.87 — stand aside until the condition resets.
Earnings
Normal technical setup
No sourced report date
Event risk is not modelled for this symbol
Deterministic evidence
AMGN-2.25%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Session internals Weak
Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.
Vs prior close-2.25%
From the open-1.38%
Range position9%
GapNo gap
QQQ confirmationConfirming (-1.06%)
SMH confirmationConfirming (-2.44%)
Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.
More stats
52W Low
$269.77
Tight Wks
0
Base
B2
SMA 200
$359.17
RS Line vs High
-4.9%
RS Line Slope
+5.1% ▲
Group Rank
#15/58
ADR%
2.0%
ATR(14)
$11.09 (2.9%)
Vol Pace (live)
N/A
U/D Vol
0.93
A/D Days
13A / 15D
A/D Rating
D
VDU Bars
0/10 d
AMGN Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Technical Analysis Report Card
$AMGN · $382.47 · as of 2026-09-10 · multi-factor read
49
/ 100
Reference read from price & volume only — the verdict at the top of the page decides the action.
Trend · Daily / Weekly / Monthly
Daily
▬ Sideways / consolidating
Weekly
▬ Sideways / consolidating
Monthly
▬ Sideways / consolidating
Moving Averages
50-day$398.78 ↓
100-day$369.69 ↑
200-day$359.17 ↑
Bullish (50 > 200)
RSI (14)
Reading33.1 · Bearish
Bearish momentum — sellers in control.
MACD (12/26/9)
StateWeakening
Histogram-8.257
Weakening — MACD slipped below its signal line. Histogram contracting.
Bollinger Bands (20,2)
%B / Width-10% · 17.6%
Piercing the lower band — capitulation or strong selling.
Volume · Buyer vs Seller
Up/Down vol0.93 · Neutral
Rel volume1.35×
Balanced — up/down volume is roughly even; no clear hand. Recent volume is expanding versus its baseline.
Support & Resistance
R · $391.29swing level
R · $398.00swing level
R · $447.0352-week high
Price · $382.47now
S · $361.39swing level
S · $353.95swing level
S · $344.95swing level
Fibonacci · Uptrend swing
23.6%$417.17
38.2%$398.70
50.0% ◄ price here$383.77
61.8%$368.85
78.6%$347.59
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for AMGN — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Above 200-day MA50/200 bullish
Want this read in a legend's voice?
Ask a Legend about AMGN
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini B
Trend-template read: 10/12 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $437.23, MA150 $366.88, MA200 $358.45
1.2 150-day MA > 200-day MAMA150 $366.88 vs MA200 $358.45
Failing evidence
2. Quarterly EPS growth ≥ 25%+22.1% QoQ
2. Revenue growth ≥ 20% YoY+10.0% YoY
Avoid
O'Neil D
CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
A: Annual earnings & revenue qualityRev +10.0% | ROE 89.3%
N: Near 52-week high or RS line new high2.2% below high | RS line new high: False
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+22.1% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 75
Watch
Weinstein C
Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $437.23 vs MA200 $358.45
Failing evidence
Volume expansion above averageVolume ratio 0.68x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
Watch
Livermore B
Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$437.23
Relative strengthRS 75
Failing evidence
Volume vs average0.68x
Pivotal point cleared on expanding volumeNot confirmed
Watch
Darvas B
Box-theory read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$437.23
Relative strengthRS 75
Failing evidence
Volume vs average0.68x
Box top broken on heavy volumeNot confirmed
Watch
Wyckoff B
Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$437.23
Relative strengthRS 75
Failing evidence
Volume vs average0.68x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
Base & Breakout
Breakout follow-through
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▲ Rising
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net +3
Fundamentals & leadership quality — Minervini’s published criteria · 4/7 met
B
4/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
+22%
Revenue growth ≥20% YoY
+10%
Gross margin ≥30%
74%
ROE ≥17%
89%
RS rating ≥80 (leadership)
75
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-14.4%
Method Playbook
Trade it like Darvas
EXACT LEVELS · PRO
Darvas B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro levelPublished-method rule: Use the top of the active Darvas box near the high as the mechanical breakout boundary.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Require price to clear the box top with volume confirmation; movement inside the box remains observation, not a trigger.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Start below the active box support or the canonical structural stop that proves the breakout failed.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: As higher boxes form, raise the stop beneath the newest confirmed box floor; the stop moves up only.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit when price breaks the active box floor or decisively falls back through the breakout structure.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis (historical)
Cup & Handle
Historical replay: +20% before −8% within 40 sessions: 21% (n=53) · source bars 2025-03-17–2026-09-04 · avg +1.9% per setup (+0.24R)
⚠ 3rd-stage base
89
setup score
RS Score
75
Trend template
7/8
CANSLIM
78.4* (B)
16.4% cup depth
4.7% handle
Why This Setup?
Cup & Handle · schematic
depth=16.4%, handle_pb=4.7%, lips_diff=11.5%, upper_half=yes, u_shape=yes, near_pivot=yes, orderly=yes | Strong trend (8/8) | Good RS (75) | High-confidence pattern (84%) | Accumulation (1.9× up/dn vol) | Power Trend | Stage 2 | Readiness 73/100 (approaching) | CANSLIM 78.4 (B) | ⚠ 3rd-stage base
The Universal Edge Check · context only
What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.
1/7
universals met
- Risk is defined — not met No stop — undefined risk
- A relative-strength leader — partly met RS rank 69 — middling
- Asymmetric reward — partly met No target set
- Clear of earnings — partly met Report date unknown
- Not chasing (in range) — partly met Pivot distance unknown
- Volume confirms — partly met 1.4× average — light
- In a confirmed uptrend — met Stage 2 · Trend template 7/8
Minervini Trend Template
7/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$382.47 vs SMA150 $367.66 / SMA200 $359.17
SMA 150 above SMA 200
SMA150 $367.66 vs SMA200 $359.17
SMA 200 trending up
Slope +11.03 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $398.78
Price above SMA 50
$382.47 vs SMA50 $398.78
30%+ above 52-week low
+41.8% from $269.77
Within 25% of 52-week high
-14.4% from $447.03
RS score above 70
RS 75
Fundamentals
52W Range
64%
Mkt Cap SEC
206.8B
EPS QoQ
+22%
Rev YoY
+10%
ROE
89%
Gross Margin
74%
D/E
6.31
EPS TTM
$14.23
P/E TTM
26.9x
Float
541M
Company
Company profile
Amgen Inc.
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B
78.4* CANSLIM
* disqualified on C, M
C · Curr. EPS
88
A · Annual EPS
100
N · New Highs
100
S · Supply/Demand
55
L · Leader RS
75
I · Inst. Spons.
96
M · Market
30
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
8/8
W. RS
90
W. Support
$320.52
W. Resist
$447.03
Weekly Structure
Trend
Neutral
Tight Weeks
0
Confirmation
Neutral
Get the full picture on AMGN
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.
Start 7-Day Free Trial